{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:48:08Z","timestamp":1785858488380,"version":"3.56.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1097\/01.psy.0000171193.28044.d8","type":"journal-article","created":{"date-parts":[[2005,10,4]],"date-time":"2005-10-04T12:21:41Z","timestamp":1128428501000},"page":"773-777","source":"Crossref","is-referenced-by-count":33,"title":["Irritability Rather Than Depression During Interferon Treatment Is Linked to Increased Tryptophan Catabolism"],"prefix":"10.1097","volume":"67","author":[{"given":"Sascha","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido P.","family":"Kema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth B.","family":"Haagsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim C.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pax H.B.","family":"Willemse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan A.","family":"den Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth G.E.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Korf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210213","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons.","volume":"67","author":"Stark","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"R2-15-20210213","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/archinte.1987.00370090055011","article-title":"Psychiatric complications of long-term interferon alfa therapy.","volume":"147","author":"Renault","year":"1987","journal-title":"Arch Intern Med"},{"key":"R3-15-20210213","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1017\/S0033291799001774","article-title":"Interferons, serotonin and neurotoxicity.","volume":"30","author":"Menkes","year":"2000","journal-title":"Psychol Med"},{"key":"R4-15-20210213","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/clinchem\/38.4.534","article-title":"Improved diagnosis of carcinoid tumors by measurement of platelet serotonin.","volume":"38","author":"Kema","year":"1992","journal-title":"Clin Chem"},{"key":"R5-15-20210213","first-page":"611","article-title":"Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.","volume":"152","author":"Sanni","year":"1998","journal-title":"Am J Pathol"},{"key":"R6-15-20210213","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/978-1-4684-5952-4_39","article-title":"Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS.","volume":"294","author":"Brown","year":"1991","journal-title":"Adv Exp Med Biol"},{"key":"R7-15-20210213","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0006-3223(03)00173-2","article-title":"Interferon-alpha-induced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment.","volume":"54","author":"Capuron","year":"2003","journal-title":"Biol Psychiatr"},{"key":"R8-15-20210213","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0163-8343(02)00239-6","article-title":"Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective study.","volume":"25","author":"Horikawa","year":"2003","journal-title":"Gen Hosp Psychiatry"},{"key":"R9-15-20210213","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0447.1994.tb01559.x","article-title":"New versions of World Health Organization instruments for the assessment of mental disorders.","volume":"90","author":"Janca","year":"1994","journal-title":"Acta Psychiatr Scand"},{"key":"R10-15-20210213","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/clinchem\/47.10.1811","article-title":"Profiling of tryptophan-related plasma indoles in patients with carcinoid tumors by automated, on-line, solid-phase extraction and HPLC with fluorescence detection.","volume":"47","author":"Kema","year":"2001","journal-title":"Clin Chem"},{"key":"R11-15-20210213","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/clinchem\/38.4.534","article-title":"Improved diagnosis of carcinoid tumors by measurement of platelet serotonin.","volume":"38","author":"Kema","year":"1992","journal-title":"Clin Chem"},{"key":"R12-15-20210213","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/hep.510260127","article-title":"Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy.","volume":"26","author":"Deutsch","year":"1997","journal-title":"Hepatology"},{"key":"R13-15-20210213","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF00685797","article-title":"Serotonin metabolism following platinum-based chemotherapy combined with the serotonin type-3 antagonist tropisetron.","volume":"36","author":"Schroder","year":"1995","journal-title":"Cancer Chemother Pharmacol"},{"key":"R14-15-20210213","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0091-3057(01)00670-0","article-title":"The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels.","volume":"71","author":"Young","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"R15-15-20210213","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0193-953X(05)70319-1","article-title":"The neurobiology of impulsive aggression.","volume":"20","author":"Kavoussi","year":"1997","journal-title":"Psychiatr Clin North Am"},{"key":"R16-15-20210213","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(98)04793-X","article-title":"Treatment with interferon-\u03b1 in patients with chronic hepatitis and mood or anxiety disorders.","volume":"354","author":"Pariante","year":"1999","journal-title":"Lancet"},{"key":"R17-15-20210213","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/0269881104040230","article-title":"Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms.","volume":"18","author":"Maddock","year":"2004","journal-title":"J Psychopharmacol"},{"issue":"Suppl 1","key":"R18-15-20210213","first-page":"67","article-title":"Safety of combination interferon alfa-2b\/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients.","volume":"19","author":"Maddrey","year":"1999","journal-title":"Semin Liver Dis"},{"key":"R19-15-20210213","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1067\/mcp.2000.110973","article-title":"Pegylated interferon alpha2b: pharmacokinetics, pharmacodynamics, safety and preliminary efficacy data. Hepatitis C Intervention Therapy group.","volume":"68","author":"Glue","year":"2000","journal-title":"Clin Pharmacol Ther"}],"container-title":["Psychosomatic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.psy.0000171193.28044.d8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:53:57Z","timestamp":1785855237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006842-200509000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.psy.0000171193.28044.d8","relation":{},"ISSN":["0033-3174"],"issn-type":[{"value":"0033-3174","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}